Guaifenesin And Dextromethorphan Hbr Tablet, Extended Release
Product Images NDC 71179-011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Dextromethorphan Hbr (NDC 71179-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vespyr Brands Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1200 mg/60 mg Blister Carton (21 (3 x 7)Tablets))

Package Label-principal Display Panel (1200 mg/60 mg Blister Carton (21 (3 x 7)Tablets))
The text is a description of a cough and expectorant product called Contac. It contains active ingredients such as Dextromethorphan Hydiobromide USP and Guifenesin USP that control coughing, thin and loosen mucus. The product is in extended-release tablets and should not be used by children under 12 years without a doctor's prescription. Additionally, it gives warnings and directions on how to use the product. If you experience persistent headaches, severe coughing, or coughing for more than a day, you should stop using the product and see a doctor. Otherwise, the inactive ingredients in the product include coldal sicon oid, ypromellos, magnesium searae, microcrystalie elose, povcone, pregeatinized sarch (maze). Finally, the manufacture is Vespyr BrandsĀ®, and you could reach out to them for more information via the available phone number.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.